Nutritional Growth Solutions Ltd. (ASX:NGS)
Australia
· Delayed Price · Currency is AUD
0.0200
0.00 (0.00%)
At close: Feb 27, 2026
ASX:NGS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 1.63 | 2.48 | 2.98 | 2.95 | 3.04 | |
| Revenue Growth (YoY) | -34.42% | -16.86% | 1.26% | -3.06% | 62.57% | |
| Cost of Revenue | 1.37 | 1.67 | 2.14 | 1.51 | 1.68 | |
| Gross Profit | 0.26 | 0.81 | 0.84 | 1.44 | 1.36 | |
| Selling, General & Admin | 1.88 | 3.42 | 3.62 | 5.4 | 5.2 | |
| Research & Development | - | 0.22 | 0.29 | 0.39 | 0.9 | |
| Operating Expenses | 1.88 | 3.64 | 3.91 | 5.78 | 6.09 | |
| Operating Income | -1.62 | -2.83 | -3.07 | -4.34 | -4.73 | |
| Interest Expense | -0.31 | -0.08 | -0.07 | -0.02 | -0.07 | |
| Interest & Investment Income | 0.22 | 0.01 | 0.25 | 0.11 | 0.02 | |
| Pretax Income | -1.71 | -2.9 | -2.89 | -4.25 | -4.78 | |
| Net Income | -1.71 | -2.9 | -2.89 | -4.25 | -4.78 | |
| Net Income to Common | -1.71 | -2.9 | -2.89 | -4.25 | -4.78 | |
| Shares Outstanding (Basic) | - | 69 | 19 | 13 | 10 | |
| Shares Outstanding (Diluted) | - | 69 | 19 | 13 | 10 | |
| Shares Change (YoY) | - | 257.22% | 48.60% | 26.45% | 121.16% | |
| EPS (Basic) | - | -0.04 | -0.15 | -0.33 | -0.47 | |
| EPS (Diluted) | - | -0.04 | -0.15 | -0.33 | -0.47 | |
| Free Cash Flow | -1.21 | -1.93 | -2.35 | -4.83 | -3.82 | |
| Free Cash Flow Per Share | - | -0.03 | -0.12 | -0.37 | -0.37 | |
| Gross Margin | 15.67% | 32.69% | 28.22% | 48.80% | 44.77% | |
| Operating Margin | -99.57% | -114.15% | -102.92% | -147.40% | -155.69% | |
| Profit Margin | -105.10% | -116.85% | -96.95% | -144.18% | -157.24% | |
| Free Cash Flow Margin | -74.43% | -77.59% | -78.65% | -164.00% | -125.66% | |
| EBITDA | -1.6 | -2.8 | -3.01 | -4.32 | -4.63 | |
| EBITDA Margin | -98.59% | -112.90% | -100.94% | -146.62% | -152.40% | |
| D&A For EBITDA | 0.02 | 0.03 | 0.06 | 0.02 | 0.1 | |
| EBIT | -1.62 | -2.83 | -3.07 | -4.34 | -4.73 | |
| EBIT Margin | -99.57% | -114.15% | -102.92% | -147.40% | -155.69% | |
| Advertising Expenses | - | 1.23 | 1.4 | 1.18 | 1.15 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.